More importantly, and consistent with our functional studies, miR-29a expression was negatively correlated with TET1, TET2, and TET3 expression in HCC patients (n=54, r =−0.4, −0.33, and −0.29, respectively; all P<0.05; Figure 6c). This evidence concerns the gene TET2 and hepatocellular carcinoma.